JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 7, 2004; DOI: 10.1124/jpet.104.071035


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.071035v1
jpet.104.071035v2
311/2/720    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Czoty, P. W.
Right arrow Articles by Bergman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Czoty, P. W.
Right arrow Articles by Bergman, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*d-METHAMPHETAMINE
Medline Plus Health Information
*Methamphetamine


Received for publication May 7, 2004.
Revised June 25, 2004.
Accepted for publication July 7, 2004.

Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors

Paul W. Czoty 1, Chinnasamy R. Ramanathan 2, Nicole H. Mutschler 1, Alexandros Makriyannis 2, Jack Bergman 1*

1 McLean Hospital, Harvard Medical School 2 University of Connecticut

* Address correspondence to: E-mail: jbergman{at}hms.harvard.edu

Abstract

The involvement of brain monoamine systems in the discriminative stimulus effects of methamphetamine (MA) was studied in squirrel monkeys by evaluating the effects of differentially-selective monoamine uptake inhibitors alone and in combination. In monkeys discriminating i.m. injections of 0.3 mg/kg MA from saline, methamphetamine (0.01-0.3 mg/kg) and dopamine transporter (DAT) inhibitors, including GBR 12909 (1.0-17.8mg/kg) and its analogs AM2502 (1.0-17.8 mg/kg), AM2506 (1.0-30.0 mg/kg), AM2515 (1.0-17.8 mg/kg) and AM2517 (1.0-5.6 mg/kg), produced dose-related increases in responding on the MA-associated lever and, at the highest doses, full substitution. The time course of MA-like effects was similar for equivalent (3.0 mg/kg) doses of GBR 12909 and its most potent analog, AM2517. Unlike the DAT blockers, the selective serotonin (5-HT) uptake inhibitor clomipramine (1.0-10.0 mg/kg) and the selective norepinepherine (NE) uptake inhibitor desipramine (1.0-10 mg/kg) produced responding primarily on the saline lever. The selective NE uptake inhibitor nisoxetine partially substituted at the highest dose tested (10.0 mg/kg). Pretreatment with GBR 12909 or AM2517 enhanced the discriminative stimulus effects of MA, shifting the dose-effect curve leftward. The NE uptake inhibitors desipramine or nisoxetine also enhanced the discriminative stimulus effects of MA, whereas clomipramine only attenuated them. These results support the view that dopaminergic mechanisms play a prominent role in the discriminative stimulus effects of MA in monkeys, whereas involvement of serotonergic and noradrenergic systems may be limited to a modulatory role.


Key words: dopamine, drug abuse, drug discrimination, methamphetamine, nonhuman primates, serotonin


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. M. Platt, J. K. Rowlett, and R. D. Spealman
Noradrenergic Mechanisms in Cocaine-Induced Reinstatement of Drug Seeking in Squirrel Monkeys
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 894 - 902.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.